DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $429 | -31.0% | 1,718 | -30.4% | 0.14% | -5.8% |
Q1 2023 | $622 | -100.0% | 2,468 | -63.8% | 0.15% | -81.8% |
Q1 2021 | $1,536,000 | -79.2% | 6,824 | -79.5% | 0.85% | -76.7% |
Q4 2020 | $7,389,000 | +39.1% | 33,262 | -32.0% | 3.63% | +1770.6% |
Q3 2018 | $5,312,000 | -79.4% | 48,886 | -81.3% | 0.19% | -79.0% |
Q2 2018 | $25,839,000 | +1134.5% | 261,847 | +1125.1% | 0.93% | +1072.2% |
Q1 2018 | $2,093,000 | +196.5% | 21,374 | +181.1% | 0.08% | +192.6% |
Q4 2017 | $706,000 | -97.5% | 7,604 | -97.8% | 0.03% | -97.5% |
Q2 2017 | $28,689,000 | +84.0% | 339,956 | +86.5% | 1.08% | +81.9% |
Q1 2017 | $15,588,000 | -32.9% | 182,248 | -38.9% | 0.59% | -37.4% |
Q4 2016 | $23,221,000 | +205.4% | 298,318 | +207.5% | 0.95% | +198.4% |
Q3 2016 | $7,604,000 | +57.7% | 97,005 | +103.2% | 0.32% | +65.1% |
Q2 2016 | $4,821,000 | +373.1% | 47,737 | +344.3% | 0.19% | +380.0% |
Q1 2016 | $1,019,000 | -95.2% | 10,744 | -95.3% | 0.04% | -95.3% |
Q4 2015 | $21,424,000 | +57.0% | 230,661 | +44.0% | 0.84% | +34.7% |
Q3 2015 | $13,645,000 | +2327.9% | 160,137 | +2320.8% | 0.63% | +3030.0% |
Q1 2015 | $562,000 | -51.1% | 6,615 | -56.3% | 0.02% | -42.9% |
Q3 2014 | $1,149,000 | -96.2% | 15,123 | -96.3% | 0.04% | -95.8% |
Q1 2014 | $30,435,000 | +286.8% | 405,806 | +298.2% | 0.82% | +255.2% |
Q4 2013 | $7,868,000 | – | 101,918 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |